Oncocyte Appoints Andrea James as Chief Financial Officer
June 17, 2024 16:05 ET
|
OncoCyte Corporation
Oncocyte Appoints Seasoned Finance Executive Andrea James as Chief Financial Officer
UPDATE -- PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion
June 17, 2024 14:07 ET
|
PRISM MarketView
PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion
PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion
June 17, 2024 10:17 ET
|
PRISM MarketView
PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion
BranchOut Food Inc. Secures Fourth EnWave Dehydration Machine for New Peru Factory with $40M Production Capacity
June 17, 2024 08:00 ET
|
BranchOut Food Inc.
BranchOut Food Inc. Secures Fourth EnWave Dehydration Machine for New Peru Factory with $40M Production Capacity
Holiday Island Holdings, Inc. Has Finalized Funding for Its Windy Point Oil Extraction Development
June 17, 2024 07:30 ET
|
Holiday Island Holdings, Inc.
HOLIDAY ISLAND HOLDINGS, INC. HAS FINALIZED FUNDING FOR ITS WINDY POINT OIL EXTRACTION DEVELOPMENT
Formation Minerals, Inc. Announces Corporate Update
June 13, 2024 08:45 ET
|
Formation Minerals, Inc.
Formation Minerals, Inc. Announces Corporate Update
Tevogen Bio Set to Join Russell 3000® Index
June 12, 2024 15:45 ET
|
Tevogen Bio Inc
Tevogen Bio is set to join the Russell 3000® Index effective at the open of US equity markets on Monday, July 1.
CTR Investments & Consulting, Inc. Updated Status to Current OTC Pink Sheet Plans for OTCQB Listing
June 12, 2024 09:42 ET
|
CTR Investments & Consulting, Inc.
CTR Investments & Consulting, Inc. (OTCPK: CIVX) is Seeking Strong Merger Candidate for listing to OTCQB
Rodedawg (OTC: RWGI) Launches TikTok Shop to Expand into Global E-Commerce Market
June 12, 2024 08:00 ET
|
Rodedawg International Industries, Inc.
Rodedawg (OTC: RWGI) Launches TikTok Shop to Expand into Global E-Commerce Market
SIPP Industries Announces Strategic R&D Agreement with Calypso Pharmaceuticals to Develop Nano-Emulsified Topical Targeting Melanoma
June 11, 2024 12:46 ET
|
Sipp Industries, Inc.
SIPP Industries Announces Strategic R&D Agreement with Calypso Pharmaceuticals to Develop Nano-Emulsified Topical Targeting Melanoma